Freeline Therapeutics Holdings Limited
- Company number
- 12546479
- Status
- Dissolved
- Type
- Private Limited Company
- Incorporated
- 3 Apr 2020
- Dissolved
- 28 Jul 2026
- Nature of business
- Activities of other holding companies n.e.c.
Research and experimental development on biotechnology - Corporate group
- Spur Therapeutics Holdings Limited (4 companies)
Registered office
Previous names
- Freeline Therapeutics Holdings PLC (until 9 May 2024)
- Freeline Therapeutics Holdings Limited (until 15 Jul 2020)
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| SILVER, Brian Michael | Director | 3 Apr 2020 | 26 Jun 2020 |
| HEGGIE, Theresa Marie | Director | 26 Jun 2020 | 15 Aug 2021 |
| WARRINER, Benjamin Charles George | Secretary | 6 Jul 2020 | 17 Dec 2021 |
| DIAMOND, JR., Stephen Patrick | Secretary | 17 Dec 2021 | 15 Jul 2022 |
| NATHWANI, Amit Chunilal, Dr | Director | 26 Jun 2020 | 30 Mar 2023 |
| SCHNEIDER, Paul | Director | 30 Mar 2023 | 20 Feb 2024 |
| LOVE, Colin Andrew, Dr | Director | 10 Mar 2021 | 20 Feb 2024 |
| CHODAKEWITZ, Jeffrey Allan | Director | 26 Jun 2020 | 20 Feb 2024 |
| ANDREWS, Martin | Director | 26 Jun 2020 | 20 Feb 2024 |
| GREGORY, Julia Paige | Director | 26 Jun 2020 | 20 Feb 2024 |
| HOLLOWOOD, Christopher, Dr | Director | 26 Jun 2020 | 15 Apr 2024 |
| SCHNEIDER, Paul Matthew | Director | 15 Apr 2024 | |
| BIRCHER III, James Albert | Director | 15 Apr 2024 | |
| MCCORKLE IV, Pope "Chip" | Secretary | 15 Jul 2022 | |
| PARINI, Michael John | Director | 15 Aug 2021 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Mr Brian Michael Silver | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
3 Apr 2020 | 26 Jun 2020 |
| Benjamin Charles Warriner | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
26 Jun 2020 | 27 Jun 2020 |
| Syncona Limited | Ownership Of Shares 50 To 75 Percent Voting Rights 50 To 75 Percent |
27 Jun 2020 | 15 Apr 2024 |
| Spur Therapeutics Holdings Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
20 Feb 2024 |
Accounts
| Year ended |
|---|
| 31 Dec 2024 |
| 31 Dec 2023 |
| 31 Dec 2022 |
| 31 Dec 2021 |
| 31 Dec 2020 |
Connections
Owned by
Freeline Therapeutics Holdings Limited → Spur Therapeutics Holdings Limited
Controls
- Freeline Holdings (UK) Limited (12577387)
Directors’ other companies
- BIRCHER III, James Albert - Director at Swanbio Therapeutics Limited
- PARINI, Michael John - Director at Freeline Holdings (UK) Limited
- SCHNEIDER, Paul Matthew - Director at Swanbio Therapeutics Limited
Companies at the same address
- Spur Therapeutics Holdings Limited (15295548)
- Spur Therapeutics Limited (09500073)
- Swanbio Therapeutics Limited (10942620)